P

Inventor

ALAMI MOUAD

FR14 patents
⚠️ This page may combine multiple inventors who share the name “ALAMI MOUAD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INST NAT SANTE RECH MED

3 patents
US11376245B2Jul 5, 2022

Dizocilpine derivatives as peripheral NMDA receptor antagonists

INST NAT SANTE RECH MED3 citations68
US12274694B2Apr 15, 2025

Dizocilpine derivatives as peripheral NMDA receptor antagonists

INST NAT SANTE RECH MED0 citations57
US10538482B2Jan 21, 2020

Adamantane and memantine derivatives as peripheral NMDA receptor antagonists

INST NAT SANTE RECH MED0 citations35

UNIV PARIS SACLAY

3 patents
US12371417B2Jul 29, 2025

Compounds with tubulin polymerisation inhibitory activity and immunomodulatory properties

UNIV PARIS SACLAY0 citations53
US12172965B2Dec 24, 2024

Drug conjugate comprising quinoline derivatives

UNIV PARIS SACLAY0 citations53
US11634405B2Apr 25, 2023

Compounds with tubulin polymerisation inhibitory activity and immunomodulatory properties

UNIV PARIS SACLAY0 citations53

SANOFI SYNTHELABO

2 patents
US6407253B1Jun 18, 2002

Method for preparing 4-methyl-biphenyl derivatives

SANOFI SYNTHELABO5 citations60
US6392080B1May 21, 2002

Process for the preparation of a cyanobiphenyl

SANOFI SYNTHELABO2 citations60

ROUSSY INST GUSTAVE

2 patents
US11110105B2Sep 7, 2021

Compounds, composition and uses thereof for treating cancer

ROUSSY INST GUSTAVE0 citations49
US12213978B2Feb 4, 2025

Madrasin-derivative compounds, composition and uses thereof for treating cancer

ROUSSY INST GUSTAVE0 citations40

INSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICAL INSERM

1 patent
US11944616B2Apr 2, 2024

Dizocilpine derivatives as peripheral NMDA receptor antagonists

INSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICAL INSERM0 citations51

ALAMI MOUAD

1 patent
US8273768B2Sep 25, 2012

Iso CA-4 and analogues thereof as potent cytotoxic agents inhibiting tubuline polymerization

ALAMI MOUAD2 citations48

ADPUERIVITAM

1 patent
US11247982B2Feb 15, 2022

NMDA receptor modulators, compositions comprising same and use of these compounds in the treatment of diseases involving the central nervous system

ADPUERIVITAM0 citations32

CENTRE NAT RECH SCIENT

1 patent
US10653694B2May 19, 2020

Cytotoxic compounds which are inhibitors of the polymerisation of tubulin

CENTRE NAT RECH SCIENT0 citations31